Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Open, Two-stage, Multicenter, Monotherapy, Phase II Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors After Failure or Intolerability to Standard Treatment

Next Previous
X
Search
Trial Profile

Open, Two-stage, Multicenter, Monotherapy, Phase II Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors After Failure or Intolerability to Standard Treatment

Status: Recruiting
Phase of Trial: Phase II

Latest Information Update: 12 Jul 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Depoxythilone (Primary)
  • Indications Cholangiocarcinoma; Gastric cancer; Head and neck cancer; Oesophageal cancer; Ovarian cancer; Pancreatic cancer; Solid tumours; Squamous cell cancer
  • Focus Therapeutic Use
  • Sponsors Beijing Biostar Technologies

    • Most Recent Events

    • 04 Jun 2024 Results(From March 18th 2021 to October 13th 2022, n=79) report efficacy and safety data from stage I and stage II for interim analysis, presented at the 60th Annual Meeting of the American Society of Clinical Oncology
    • 07 Nov 2023 Planned End Date changed from 30 Dec 2023 to 30 Dec 2024.
    • 07 Nov 2023 Planned primary completion date changed from 15 Aug 2023 to 15 Mar 2024.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top